Search Results - "O'Moráin, C"

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) by Dinis-Ribeiro, M, Areia, M, de Vries, A C, Marcos-Pinto, R, Monteiro-Soares, M, O'Connor, A, Pereira, C, Pimentel-Nunes, P, Correia, R, Ensari, A, Dumonceau, J M, Machado, J C, Macedo, G, Malfertheiner, P, Matysiak-Budnik, T, Megraud, F, Miki, K, O'Morain, C, Peek, R M, Ponchon, T, Ristimaki, A, Rembacken, B, Carneiro, F, Kuipers, E J

“…Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In…”
Get more information

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report by Malfertheiner, P, Megraud, F, O’Morain, C, Bazzoli, F, El-Omar, E, Graham, D, Hunt, R, Rokkas, T, Vakil, N, Kuipers, E J

“…Background: Guidelines on the management of Helicobacter pylori, which cover indications for management and treatment strategies, were produced in 2000. Aims:…”
Get full text

Validation of the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI or Niv score): a multicenter prospective study by Niv, Y, Ilani, S, Levi, Z, Hershkowitz, M, Niv, E, Fireman, Z, O'Donnel, S, O'Morain, C, Eliakim, R, Scapa, E, Kalantzis, N, Kalantzis, C, Apostolopoulos, P, Gal, E

“…The Capsule Endoscopy Crohn's Disease Activity Index (CECDAI or Niv score) was devised to measure mucosal disease activity using video capsule endoscopy (VCE)…”
Get more information

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report by Malfertheiner, P, Megraud, F, O'Morain, C A, Gisbert, J P, Kuipers, E J, Axon, A T, Bazzoli, F, Gasbarrini, A, Atherton, J, Graham, D Y, Hunt, R, Moayyedi, P, Rokkas, T, Rugge, M, Selgrad, M, Suerbaum, S, Sugano, K, El-Omar, E M

“…Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects…”
Get more information

The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis by Rokkas, T, Gisbert, JP, Niv, Y, O’Morain, C

“…Background In humans there are epidemiological data suggesting a protective effect of Helicobacter pylori (H. pylori) infection against the development of…”
Get full text

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management by Dignass, A., Van Assche, G., Lindsay, J.O., Lémann, M., Söderholm, J., Colombel, J.F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., Hommes, D.W., Michetti, P., O'Morain, C., Öresland, T., Windsor, A., Stange, E.F., Travis, S.P.L.

Get full text

Nature meets nurture: molecular genetics of gastric cancer by Milne, Anya N, Carneiro, F, O'Morain, C, Offerhaus, G. J. A

“…The immensity of genes and molecules implicated in gastric carcinogenesis is overwhelming and the relevant importance of some of these molecules is too often…”
Get full text

Review article: defining remission in ulcerative colitis by Travis, S. P. L., Higgins, P. D. R., Orchard, T., Van Der Woude, C. J., Panaccione, R., Bitton, A., O’Morain, C., Panés, J., Sturm, A., Reinisch, W., Kamm, M. A., D’Haens, G.

“…Aliment Pharmacol Ther 2011; 34: 113–124 Summary Background  There is no international agreement on scoring systems used to measure disease activity in…”
Get full text

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report by Malfertheiner, Peter, Megraud, Francis, O'Morain, Colm A, Atherton, John, Axon, Anthony T R, Bazzoli, Franco, Gensini, Gian Franco, Gisbert, Javier P, Graham, David Y, Rokkas, Theodore, El-Omar, Emad M, Kuipers, Ernst J

“…Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H…”
Get more information

Review article: the effects of antitumour necrosis factor‐α on bone metabolism in inflammatory bowel disease by Veerappan, S. G., O’Morain, C. A., Daly, J. S., Ryan, B. M.

“…Summary Background  Patients with inflammatory bowel disease (IBD) are at increased risk of osteoporosis. A number of studies have emerged in recent years…”
Get full text

Review article: nutrition and adult inflammatory bowel disease by Goh, J, O'Morain, C A

“…Major advances in the understanding of the aetio-pathogenesis and genetics of inflammatory bowel disease have been accompanied by an escalation in the…”
Get full text

European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations by Caprilli, R, Gassull, M A, Escher, J C, Moser, G, Munkholm, P, Forbes, A, Hommes, D W, Lochs, H, Angelucci, E, Cocco, A, Vucelic, B, Hildebrand, H, Kolacek, S, Riis, L, Lukas, M, de Franchis, R, Hamilton, M, Jantschek, G, Michetti, P, O’Morain, C, Anwar, M M, Freitas, J L, Mouzas, I A, Baert, F, Mitchell, R, Hawkey, C J

“…This third section of the European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn’s disease concerns postoperative recurrence,…”
Get full text

Nutrition and adult inflammatory bowel disease by Goh, J., O'Morain, C. A.

“…Summary Major advances in the understanding of the aetio‐pathogenesis and genetics of inflammatory bowel disease have been accompanied by an escalation in the…”
Get full text

Review article: reproduction in the patient with inflammatory bowel disease by HEETUN, Z. S., BYRNES, C., NEARY, P., O’MORAIN, C.

“…Summary Background  Inflammatory bowel disease (IBD) affects mainly the young population. The effect of IBD and its treatment on fertility and pregnancy is…”
Get full text

Review article: the long‐term use of proton‐pump inhibitors by RAGHUNATH, A. S., O'MORAIN, C., MCLOUGHLIN, R. C.

“…Summary More than 15 years after the launch of omeprazole in 1988, proton‐pump inhibitors remain central to the management of acid‐suppression disorders and…”
Get full text

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study by Molina‐Infante, J., Lucendo, A. J., Angueira, T., Rodriguez‐Tellez, M., Perez‐Aisa, A., Balboa, A., Barrio, J., Martin‐Noguerol, E., Gomez‐Rodriguez, B. J., Botargues‐Bote, J. M., Gomez‐Camarero, J., Huerta, A., Modolell, I., Ariño, I., Herranz‐Bachiller, M. T., Bermejo, F., McNicholl, A. G., O'Morain, C., Gisbert, J. P., Lima, A., Tejero‐Bustos, M. A., Sans, M., Mearin, F., Perez‐Lasala, J., Mañas‐Gallardo, N., Millastre, J., Gracia, M., Rodriguez‐Sanchez, J., Rancel‐Medina, F. J., Lanas, A., Prados, S.

“…Summary Background Empiric triple therapy for Helicobacter pylori should be abandoned when clarithromycin resistance rate is >15–20%. Optimisation of triple…”
Get full text

Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception by O'DONNELL, S., O'MORAIN, C.

“…Summary Background  One of the most frequently asked questions during consultation with those affected by inflammatory bowel disease is what are its effects on…”
Get full text

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) by Dinis-Ribeiro, M., Areia, M., de Vries, A. C., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., Dumonceau, J. M., Machado, J. C., Macedo, G., Malfertheiner, P., Matysiak-Budnik, T., Megraud, F., Miki, K., O’Morain, C., Peek, R. M., Ponchon, T., Ristimaki, A., Rembacken, B., Carneiro, F., Kuipers, E. J.

“…Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In…”
Get full text

Analysis of drug resistance and virulence‐factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status? by TANEIKE, I., NAMI, A., O’CONNOR, A., FITZGERALD, N., MURPHY, P., QASIM, A., O’CONNOR, H., O’MORAIN, C.

“…Summary Background  Helicobacter pylori infection is eradicated with antimicrobial agents and drug‐resistant strains make successful treatment difficult…”
Get full text

Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort by Wolters, F L, Russel, M G, Sijbrandij, J, Schouten, L J, Odes, S, Riis, L, Munkholm, P, Bodini, P, O’Morain, C, Mouzas, I A, Tsianos, E, Vermeire, S, Monteiro, E, Limonard, C, Vatn, M, Fornaciari, G, Pereira, S, Moum, B, Stockbrügger, R W

“…Background: No previous correlation between phenotype at diagnosis of Crohn’s disease (CD) and mortality has been performed. We assessed the predictive value…”
Get full text